Healthcare / Medical Care FacilitiesUpdated 2026-05-10 22:07 UTC

AGL stock hub

agilon health, inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

AGLis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

904.8M

NYSE

Market data

Live price

Current market quote for this ticker.

Current price

AGL

In the news

Latest news · AGL

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-109.6

P25 -105.6P50 -46.5P75 -3.1

ROIC-64.3

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All AGL market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

216

Groups with data

Currency

USD

Showing 216 of 216 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001831097
Company name	agilon health, inc.
Country	United States
Country code	US
Cusip	00857U206
Employees	856
Employees Change	-220%
Employees Change Percent	-20.45
Enterprise value	$706.8M
Exchange	NYSE
Financial currency	USD
First seen	2026-05-09
Industry	Medical Care Facilities
IPO Date	2021-04-15
Isin	US00857U2069
Last refreshed	2026-05-10
Market cap	$904.8M
Market cap category	Small-Cap
Price	$54.23
Price currency	USD
Rev Per Employee	6,799,362.15x
Sector	Healthcare
Sic	8090
Symbol	AGL
Website	https://www.agilonhealth.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-39.19%
EV Sales Forward	0.13x
EV/Sales	0.12x
FCF yield	-6.91%
P/B ratio	4.96x
P/S ratio	0.16x
PS Forward	0.16x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-6.69%
EBITDA Margin	-6.44%
Gross margin	-2.5%
Gross Profit	$-145.7M
Gross Profit Growth Q	28.18%
Net Income	$-354.5M
Net Income Growth Q	303.86%
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Pretax Margin	-6.4%
Profit Margin	-6.09%
Profit Per Employee	$-414,186
ROA	-14.16
Roa5y	-12.53
ROCE	-167.4
ROE	-109.6
Roe5y	-61.32
ROIC	-64.29

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-36.03%
Cagr3y	-55.43%
Cagr5y	-42.16%
EPS Growth Q	301
EPS Growth Quarters	1
EPS Growth Years	0
Revenue Growth	-2.82x
Revenue Growth Q	-7.33x
Revenue Growth Years	0x
Revenue Growth3 Y	27.79x
Revenue Growth5 Y	34.14x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$3.39
Assets	$1.5B
Cash	$231.4M
Current Assets	$1.3B
Current Liabilities	$1.3B
Debt	$33.4M
Debt Equity	$0.18
Equity	$181.4M
Interest Coverage	-56.13
Liabilities	$1.3B
Long Term Assets	$183.8M
Long Term Liabilities	$51.2M
Net Cash	$198M
Net Cash By Market Cap	$21.89
Net Cash Growth	-39.09%
Net Debt Equity	$-1.09
Tangible Book Value	$119M
Tangible Book Value Per Share	$7.17
WACC	16.91

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.04
Net Working Capital	$-167.8M
Quick ratio	0.92
Working Capital	$48.8M
Working Capital Turnover	$35.83

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.61%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-36.01%
200-day SMA	22.24
3Y total return	-91.15%
50-day SMA	20.27
50-day SMA vs 200-day SMA	50under200
5Y total return	-93.52%
All Time High	1,120.8
All Time High Change	-95.16%
All Time High Date	2021-06-18
All Time Low	7.48
All Time Low Change	625%
All Time Low Date	2026-03-31
ATR	5.76
Beta	2.3
Beta1y	5.32
Beta2y	2.59
Ch YTD	215
High	61.39
High52	85
High52 Date	2025-05-08
High52ch	-36.2%
Low	51.61
Low52	7.48
Low52 Date	2026-03-31
Low52ch	625%
Ma50ch	167.51%
Premarket Change Percent	-2.04
Premarket Price	$59.42
Premarket Volume	30,223
Price vs 200-day SMA	143.86%
RSI	75.23
RSI Monthly	40.94
RSI Weekly	70.94
Sharpe ratio	0.44x
Sortino ratio	0.9
Total Return	-0.61%
Tr YTD	215
Tr1m	226.88%
Tr1w	83.33%
Tr3m	234.75%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	12
Analyst Count Top	3
Analyst Price Target Top	$27.67
Analyst Ratings	Buy
Analyst Ratings Top	Buy
Earnings EPS Estimate	$0.95
Earnings Revenue Estimate	1,379,952,344x
Earnings Revenue Estimate Growth	-9.97x
Operating Income	$-389.4M
Operating margin	-6.69
Price target	$47.61
Price Target Change	$-12.21
Price Target Change Top	$-48.98

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	10,803,982%
Float Percent	64.76%
Net Borrowing	-3,500,000
Shares Insiders	2.12%
Shares Institutions	215.61%
Shares Out	16,683,786
Shares Qo Q	0.47%
Shares Yo Y	0.61%
Short Float	9.26%
Short Ratio	3.29
Short Shares	6

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-101.2M
Average Volume	579,885.55x
Bv Per Share	10.93
CAPEX	$-12.5M
Ch1m	226.9
Ch1w	83.33
Ch1y	-36.01
Ch3m	234.8
Ch3y	-91.15
Ch5y	-93.52
Ch6m	225.1
Change	-10.6%
Change From Open	-11.66
Close	60.66
Days Gap	1.2
Depreciation Amortization	14,805,000
Dollar Volume	46,654,014.8
Earnings Date	2026-05-06
Earnings Time	amc
EBIT	$-389.4M
EBITDA	$-374.6M
EPS	$-21.38
F Score	2
FCF	$-62.5M
FCF EV Yield	-8.85x
FCF Per Share	$-3.75
Financing CF	-7,980,000
Fiscal Year End	December
Founded	2,016
Income Tax	$1.1M
Investing CF	130,971,000
Ipr	135.8
Iprfo	-92.32
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-06
Last Report Date	2026-03-31
Last Split Date	2026-03-31
Last Split Type	Reverse
Last10k Filing Date	2026-02-25
Ma150	19.23
Ma150ch	182.01%
Ma20	30.04
Ma20ch	80.51%
Net CF	72,943,000
Next Earnings Date	2026-08-04
Open	61.39
Optionable	Yes
Position In Range	26.79
Post Close	54.23
Postmarket Change Percent	3.25
Postmarket Price	$55.99
Ppne	30,128,000
Pre Close	60.66
Price Date	2026-05-08
Ptbv Ratio	7.6
Relative Volume	1.48x
Revenue	5,820,254,000x
SBC By Revenue	0.66x
Share Based Comp	38,654,000
Tax By Revenue	0.02x
Tr6m	225.12%
Us State	Ohio
Volume	860,299
Z Score	1.55

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does AGL pay a dividend?

Capital-return profile for this ticker.

Performance

AGL stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns AGL?

Insider, institutional, and short-interest positioning.

Institutional ownership

+215.6%

Float: +64.8% of shares outstanding

Insider ownership

+2.1%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

AGL momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

75.2

Above 70: short-term overbought

Price vs 200-day MA

+143.9%

50/200-day relationship not available

Beta (5Y)

2.30

More volatile than the market

Sharpe ratio

0.44

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About AGL

Hub-level FAQ points readers to the deeper analysis pages.

What is the current AGL stock rating?

agilon health, inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full AGL analysis?

The full report lives at /stocks/AGL/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for AGL?

The latest report frames AGL around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the AGL page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.